Search
for
Sort by
Research 30 of 1000+
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Beyond Perceived Stress: Hair Cortisol is linked with Cognition and Fatigue in Black and White Patients with Multiple Sclerosis
- Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- Skin Complications Associated with Interferon-β Treatment in Patients with Multiple Sclerosis, Tehran in 2021 - 2
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Hair loss due to treatment of multiple sclerosis
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Teriflunomide in multiple sclerosis: an update
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Role of isoflavones in multiple sclerosis
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
- Erosive pustular dermatosis of the scalp and multiple sclerosis: just a coincidence?
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- Delayed Onset of Alopecia Areata in a Patient on Ocrelizumab for Multiple Sclerosis: A Case Report
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis